Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 6 I, 1996, Pages 1985-1987

  Lavoie, Annick ^a   Hall, Jesse B ^a   Olson, David M ^a   Wylam, Mark E ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ADULT; AGED; ARTICLE; CASE REPORT; FEMALE; GAS EXCHANGE; HUMAN; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; MALE; OXYGENATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; SCHOOL CHILD;

EID: 0029951898     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.6.8665066     Document Type: Article

References (13)

1. Wessel, D. A., I. Adatia, J. E. Thompson, and P. R. Hickey. 1994. Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension. Crit. Care Med. 22:930-938.
2. Rossaint, R., K. J. Falke, F. López, K. Slama, U. Pison, and W. M. Zapol. 1993. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 328:399-405.
3. Bigatello, L. M., W. E. Hurford, R. M. Kacmarek, J. D. Roberts, Jr., and W. M. Zapol. 1994. Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Anesthesiology 80:761-770.
4. Puybasset, L., J. J. Rouby, E. Mourgeon, T. E. Stewart, P. Cluzel, M. Arthaud, P. Poète, L. Bodin, A. M. Korinek, and P. Viars. 1994. inhaled nitric oxide in acute respiratory failure: dose-response curves. Intensive Care Med. 20:319-327.
5. Gerlach, H., R. Rossaint, D. Pappert, and K. J. Falke. 1993. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur. J. Clin. Invest. 23:499-502.
6. Sitbon, O., F. Brenot, A. Denjean, A. Bergeron, F. Parent, R. Azarian, P. Herve, B. Raffestin, and G. Simonneau. 1995. Inhaled nitric oxide as a screening agent in primary pulmonary hypertension: a dose-response study and comparison with prostacyclin. Am. J. Respir. Crit. Care Med. 151:384-389.
7. Roberts, J. D., Jr., P. Lang, L. M. Bigatello, G. J. Vlahakes, and W. M. Zapol. 1993. Inhaled nitric oxide in congenital heart disease. Circulation 87:447-453.
8. Foubert, L., R. Latimer, A. Oduro, S. Gray, D. Snow, J. Wallwork, and S. Large. 1993. Use of inhaled nitric oxide to reduce pulmonary hypertension after heart transplantation. J. Cardiothorac. Vasc. Anesth. 7:506-507.
9. Assreuy, J., F. Q. Cunha, F. Y. Liew, and S. Moncada. 1993. Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br. J. Pharmacol. 108:833-837.
10. Cremona, G., and T. Higenbottam. 1995. Role of prostacyclin in the treatment of primary pulmonary hypertension. Am. J. Cardiol. 75: 67A-71A.
11. Rengasamy, A., and R. A. Johns. 1993. Regulation of nitric oxide synthase by nitric oxide. Mol. Pharmacol. 44:124-128.
12. Buga, G. M., J. M. Griscavage, N. E. Rogers, and L. J. Ignarro. 1993. Negative feedback regulation of endothelial cell function by nitric oxide. Circ. Res. 73:808-812.
13. Archer, S. L., K. Rist, D. P. Nelson, E. G. DeMaster, N. Cowan, and E. K. Weir. 1990. Comparison of the hemodynamic effects of nitric oxide and endothelium-dependent vasodilators in intact lungs. J. Appl. Physiol. 68:735-747.